TY - ADVS TI - Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism AU - Stingl (formerly Kirchheiner), Julia A2 - Daly, Ann PY - 2007 DA - 2007/10/01 N1 - Updated at 2016/07/31 UR - https://hstalks.com/bs/698/ AB - Genetic variability in pharmacokinetics, Polymorphic drug-metabolizing enzymes (Cytochrome P450), Implementation of pharmacogenetics in drug therapy, Risks and benefits of being a poor metabolizer, Limitations of genetics-based dose adjustments, Future clinical study directions in pharmacogenetics DB - The Biomedical & Life Sciences Collection SN - 2056-452X ID - 1087 PB - Henry Stewart Talks ER -